Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion type Assertion NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_head.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion description "[Therefore, AAV-HGFK1+Ad-p53 cocktail therapy has a significantly higher therapeutic effect than AAV-HGFK1 or Ad-p53 alone and is a novel promising gene therapy for colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_provenance.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion evidence source_evidence_literature NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_provenance.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion SIO_000772 18790766 NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_provenance.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion wasDerivedFrom befree-20150227 NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_provenance.
- NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_assertion wasGeneratedBy ECO_0000203 NP448278.RA1hbJcFJVHRU504MtnHFNeJG9HSK0XgZetkcbTR_Mbss130_provenance.